Skip to main content
logo
UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
33.48
-0.27 (-0.80%)
At close: Oct 29, 2026, 4:00 PM EDT
32.55
-0.93 (-2.78%)
After-hours: Oct 29, 2026, 7:30 PM EDT

UroGen Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,6371,096449463205213
Market Cap Growth
69.66%143.93%-2.93%126.06%-3.94%-46.44%
Enterprise Value
1,7251,099318409184105
Last Close Price
33.4823.4210.6515.008.879.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.679.994.975.603.184.44
PB Ratio
--10.39-51.05-7.10-2.2925.34
P/TBV Ratio
-----25.34

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.1410.013.524.952.852.18

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.48-1.23-14.19-1.54-1.120.18
Net Debt / Equity Ratio
-0.67-0.0913.270.630.00-10.50
Net Debt / EBITDA Ratio
-1.33-0.081.230.640.000.97
Net Debt / FCF Ratio
-0.55-0.061.200.540.001.03
Asset Turnover
0.820.450.390.530.500.40
Inventory Turnover
1.090.971.191.871.671.52
Quick Ratio
3.183.315.594.884.714.51
Current Ratio
3.804.016.015.425.395.11
Return on Equity (ROE)
------211.55%
Return on Assets (ROA)
-18.06%-32.10%-25.77%-26.10%-38.69%-47.72%
Return on Capital Employed (ROCE)
-35.00%-81.10%-39.90%-44.60%-70.80%-94.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.90%-14.00%-28.23%-22.08%-53.60%-51.98%
FCF Yield
-9.72%-14.84%-21.60%-16.54%-42.88%-40.17%
Buyback Yield / Dilution
-4.63%-12.22%-48.70%-26.43%-2.05%-2.60%
SEC Filings: 10-K · 10-Q